Oxford Nanopore Technologies PLC – genomics firm specialising in DNA sequencing and provider of rapid Covid-19 tests – Citigroup Global Markets Ltd exercises over-allotment option on 18.5 million shares from initial public offering at 425 pence each. Company is expected to receive GBP78.6 million in gross proceeds.
Current stock price: 600.15p, up 41% from IPO price
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Read more here: Source link
